Chinese Hawthorn for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Chinese Hawthorn for Health & Longevity

Created on 09/22/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Chinese hawthorn is a sour red fruit, long a Chinese food and medicine and now sold as capsules and extracts for the heart, blood fats, and digestion. The strongest trials tested European relatives, not the Chinese species: better exercise tolerance in mild heart failure, no fewer deaths. Blood pressure falls modestly, though trials disagree; blood fats improve in multi-herb formulas. Harms are common but mild. Mislabeled products have caused poisoning. (Full Review)

Protocol

Standardized extract, European model
900–1,800 mg daily
Leaf-and-flower dry extract standardized to 18.75% oligomeric procyanidins
Whole-fruit, Chinese model
9–12 g daily
Dried Crataegus pinnatifida fruit as decoction, stir-fried slices, or granules
Time of day
With the two largest meals
With or just after food; two or three daily doses
Time to effect
Heart-failure symptoms
8 weeks or later
Nothing in the literature supports judging hawthorn before a full 8 weeks of consistent dosing
Blood lipids and blood pressure
8–16 weeks
Lipid and blood-pressure trials measured change across this window
Decision point
12 weeks
Unchanged markers at 12 weeks are a reason to stop rather than to escalate

Benefits

Contraindications
  • Pregnancy and breastfeeding, at any dose
  • New York Heart Association Class IV or any decompensated heart failure
  • Symptomatic bradycardia, sick sinus syndrome, or second- or third-degree heart block without a pacemaker; resting heart rate below 50 beats per minute
  • Resting systolic blood pressure below 100 mmHg, or documented orthostatic hypotension with falls
  • Within 90 days of a myocardial infarction or of any cardiac device implantation
  • Known gastroparesis, prior gastric bezoar, or active peptic ulcer disease (whole fruit only)
  • Documented rose-family food allergy (apple, pear, peach, almond) with systemic reactions
  • Camphor-containing circulatory drops (when hawthorn is used to lower blood pressure)
    •
Key Interactions
  • Digoxin
  • Beta-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers (metoprolol, amlodipine, lisinopril, losartan)
  • Nitrates and other vasodilators (isosorbide mononitrate, sildenafil)
  • Anticoagulants and antiplatelets (warfarin, apixaban, clopidogrel)
  • Decongestants (pseudoephedrine, phenylephrine)
  • Antacids and acid-suppressing agents (proton-pump inhibitors, calcium carbonate)
  • Blood-pressure-lowering supplements (garlic, hibiscus, beetroot nitrate, magnesium, potassium, coenzyme Q10, arginine)
  • Lipid-lowering supplements (berberine, red yeast rice, plant sterols, soluble fiber)
  • Other interventions (time-restricted eating, carbohydrate restriction, sauna)
    •

Risk & Side Effects

  • High: Dizziness and vertigo; gastrointestinal complaints
    •
  • Medium: Palpitations; headache and migraine; additive blood-pressure lowering with antihypertensive drugs; no reduction in cardiac events, with displacement risk
  • Low: Gastric phytobezoar from concentrated raw fruit; skin hypersensitivity; adulterated or misidentified products
  • Speculative: Uterine stimulation in pregnancy; additive cardiac-glycoside effect with digoxin; blood-sugar lowering alongside diabetes medication

Monitoring

Marker Target Why
Home blood pressure (seated average) Below 120/75 mmHg Primary responsive target and the main additive-risk site
Resting heart rate 50–70 beats per minute Detects excessive slowing when combined with beta-blockers or digoxin
Triglycerides Below 100 mg/dL The lipid that moved most in hawthorn trials
Total cholesterol 150–200 mg/dL Fell in the pooled hawthorn-formula trials
Low-density lipoprotein cholesterol Below 100 mg/dL, below 70 with established plaque Improved less on hawthorn than on standard drugs, so it defines the ceiling
High-density lipoprotein cholesterol Above 50 mg/dL (women), above 45 mg/dL (men) Rose in the pooled hawthorn analysis
Apolipoprotein B Below 80 mg/dL Counts artery-entering particles, a better risk marker than low-density lipoprotein cholesterol alone
Fasting glucose 75–90 mg/dL Improved in hawthorn fatty-liver arms; guards additive lowering with diabetes drugs
Glycated hemoglobin Below 5.4% Confirms whether any glucose change is real or a single-day artifact
Alanine aminotransferase Below 20 U/L (men), below 17 U/L (women) Tracks the liver-fat endpoint and screens for herb-induced liver injury
High-sensitivity C-reactive protein Below 0.5 mg/L Tests the antioxidant and anti-inflammatory claim made for the polyphenols
N-terminal pro-B-type natriuretic peptide Below 125 pg/mL Objective measure of cardiac strain where a heart indication exists
Serum digoxin (only if co-prescribed) 0.5–0.9 ng/mL Detects any additive cardiac-glycoside effect

Cadence: Baseline before starting; home blood pressure and pulse weekly throughout; full panel again at 12 weeks and, if continuing, every 6 to 12 months

Qualitative Assessment

  • Fullness, bloating, or heaviness in the two hours after a fatty or protein-heavy meal
  • Breathlessness and perceived effort at a fixed exercise workload, rated the same way each week
  • Awareness of the heartbeat at rest, and any new fluttering or skipped-beat sensation
  • Light-headedness on standing quickly, especially in the first two weeks and after any dose increase
  • Daytime energy and post-meal alertness, scored simply and consistently rather than precisely
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.